Hepatitis C Clinical Exchange Network
About Us
The Hepatitis C Clinical Exchange Network (HepCX) is a clinical peer-to-peer learning intervention coordinated by the NYC Health Department. Currently, the network includes 55 clinical providers or Hep C Champions from 38 NYC acute care hospitals. We aim to contribute to the elimination of hepatitis C in New York City.
HepCX Goals
- Improve clinical provider capacity to provide HCV screening, diagnosis, linkage to care, and treatment in NYC
- Increase the number of qualified HCV clinical providers
- Reduce systemic HCV health care barriers
By participating in HepCX, members will:
- Meet and exchange information in virtual and in-person settings
- Learn best practices in HCV screening, diagnosis, treatment and management
- Act as Hep C Champions by bringing information back to their health care facilities
HepCX Champions
The 55 Hep C Champions in the network include clinical leaders in the fields of hepatology, gastroenterology, infectious disease, and primary care. Hep C Champion are:
- Recognized and respected by peers
- Motivated and enthusiastic
- Experts in the management and treatment of hepatitis C
Past Accomplishments
Since its inception in September 2015, the HepCX network has contributed to the following:
- Doubled the number of acute care hospitals conducting hep C antibody to RNA reflex testing
- Awarded grants to six hospitals to support HCV care quality improvement projects
- Linked facilities to HCV clinical provider training through Grand Rounds and webinars
- Increased the number of providers treating HCV in NYC
Events
-
Training | Free Buprenorphine Waiver Training
Free Buprenorphine Waiver Trainings For New York City Physicians, Nurse Practitioners, and Physician Assistants Details: The NYC Department of Health and Mental Hygiene (DOHMH) is sponsoring a free Half-and-Half Buprenorphine Waiver Training in June. To register please email bupr...
-
Webinar | Medication Assisted Treatment (MAT) as HIV and Hepatitis C Prevention
The training will review basic information about MAT, hepatitis C virus (HCV) and HIV as well as how to talk to people who use drugs about MAT as effective prevention.
